CliffBio
small molecule

DIOVAN HCT

HYDROCHLOROTHIAZIDE; VALSARTAN

Loss of exclusivity—loss of exclusivity
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameDIOVAN HCT
Active ingredientHYDROCHLOROTHIAZIDE; VALSARTAN
Strength25MG;160MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2002
Marketing statusRX

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.